DUBLIN (AP) — DUBLIN (AP) — Avadel Pharmaceuticals PLC (AVDL) on Wednesday reported a loss of $27.3 million in its first quarter.
On a per-share basis, the Dublin-based company said it had a loss of 30 cents.
The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 25 cents per share.
The specialty pharmaceutical company posted revenue of $27.2 million in the period, surpassing Street forecasts. Five analysts surveyed by Zacks expected $25.1 million.
Avadel shares have increased 29% since the beginning of the year. The stock has climbed 23% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AVDL at https://www.zacks.com/ap/AVDL
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
